SUMICHEM - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.2
| Stock Code | SUMICHEM | Market Cap | 19,139 Cr. | Current Price | 382 ₹ | High / Low | 665 ₹ |
| Stock P/E | 35.3 | Book Value | 64.0 ₹ | Dividend Yield | 0.31 % | ROCE | 25.1 % |
| ROE | 18.8 % | Face Value | 10.0 ₹ | DMA 50 | 413 ₹ | DMA 200 | 471 ₹ |
| Chg in FII Hold | -0.28 % | Chg in DII Hold | 0.18 % | PAT Qtr | 86.2 Cr. | PAT Prev Qtr | 178 Cr. |
| RSI | 37.3 | MACD | -8.60 | Volume | 2,28,322 | Avg Vol 1Wk | 3,55,829 |
| Low price | 367 ₹ | High price | 665 ₹ | PEG Ratio | 7.04 | Debt to equity | 0.02 |
| 52w Index | 5.26 % | Qtr Profit Var | 2.27 % | EPS | 10.6 ₹ | Industry PE | 21.3 |
SUMICHEM (Sumitomo Chemical India Ltd) presents a mixed case for long-term investment. While the company has strong efficiency metrics (ROCE 25.1%, ROE 18.8%) and very low debt-to-equity (0.02), its high valuation (P/E 35.3 vs industry PE 21.3) and weak earnings growth (PEG ratio 7.04) make it less attractive for compounding returns. The sharp decline in quarterly PAT (₹86.2 Cr vs ₹178 Cr) also raises concerns about earnings consistency.
📈 Ideal Entry Price Zone
Considering valuations and technical trends, the ideal entry zone would be between ₹360–₹375, near the recent low (₹367) and below the current price (₹382). This range provides a margin of safety against high valuation multiples.
📊 Exit Strategy / Holding Period
If already holding, investors should adopt a cautious medium-term horizon (2–3 years). Exit strategy may be considered near ₹420–₹450 if earnings growth does not improve, or if valuations remain stretched. Long-term holding is only advisable if profitability metrics sustain and earnings growth accelerates.
✅ Positive
- Strong ROCE (25.1%) and ROE (18.8%) indicate operational efficiency
- Very low debt-to-equity ratio (0.02) reduces financial risk
- Book value (₹64) provides some valuation support
- DII holdings increased (+0.18%), showing domestic institutional confidence
⚠️ Limitation
- High P/E ratio (35.3) compared to industry PE (21.3)
- Weak EPS (₹10.6) relative to valuation
- PEG ratio of 7.04 suggests poor earnings growth relative to price
- Dividend yield of 0.31% is negligible
📰 Company Negative News
- Sharp decline in quarterly PAT (₹86.2 Cr vs ₹178 Cr)
- FII holdings decreased (-0.28%), indicating reduced foreign investor confidence
🌟 Company Positive News
- Strong ROCE and ROE metrics highlight operational strength
- Low debt levels provide financial stability
🏦 Industry
- Chemicals sector benefits from long-term demand in agriculture and industrial applications
- Industry PE (21.3) is significantly lower than SUMICHEM’s PE, suggesting overvaluation
🔎 Conclusion
SUMICHEM is not an ideal candidate for long-term investment at current valuations. Entry near ₹360–₹375 may be suitable for cautious investors, but weak earnings growth and high PEG ratio limit upside potential. Medium-term holding (2–3 years) is advisable, with exit near ₹420–₹450 unless earnings momentum improves significantly.